Why isn't this study that holds hope for those with stage 4 cancer not widely known?
One would think that a medical study that offers a possible cure for people with stage 4 cancer would be known all over the world. Sadly, that's not the case. We should not be surprised if we know anything about the total reluctance by the medical establishment in using Ivermection to treat covid-19.
The medication in this case is Fenbendazole. It's not costly. It's widely available and used in veterinary treatments. However, the patent for the drug expired in 1999, and so Fenbendazole, FBZ, is now an inexpensive generic drug. This fact alone may help to explain why there has been little interest in both the study and the effectiveness of Fenbendazole.
The study is called, "Fenbendazole as an Anticancer Agent? A Case Seires of Self-Adminstration of three Patients." Dr. John Campbell reviews the three cases and summarizes the study. The three patients all had some form of advanced cancer and after taking the drug went into remission. It's news that can bring much hope to many people. …
We must share good news. It should be front page news if the journalists were doing their jobs responsibly.